Berkeley

Myriad Genetics Appoints Sam Raha as Chief Operating Officer

Retrieved on: 
Wednesday, November 1, 2023

SALT LAKE CITY, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the appointment of Sam Raha as Chief Operating Officer (COO), effective December 11, 2023.

Key Points: 
  • SALT LAKE CITY, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the appointment of Sam Raha as Chief Operating Officer (COO), effective December 11, 2023.
  • Raha adds more than 25 years of general management, commercial, and operations experience, deeply rooted in life sciences and molecular diagnostics, to the team at Myriad Genetics.
  • In his role as COO, he will be responsible for driving the company’s lab operations, customer service initiatives, and product development innovations.
  • “Sam is an accomplished leader who understands how to build teams and drive a patient-centric culture, with a proven ability to define, execute and deliver profitable growth for companies within the diagnostics space,” said Paul Diaz, President and CEO, Myriad Genetics.

BCTCares Foundation Raises $65,000 To Feed Local Food-Insecure Children Through Annual Pack the 'Pack Campaign

Retrieved on: 
Monday, October 30, 2023

"Our employee team set an ambitious goal to exceed last year's donations," remarked Alice P. Frazier, President and CEO of BCT.

Key Points: 
  • "Our employee team set an ambitious goal to exceed last year's donations," remarked Alice P. Frazier, President and CEO of BCT.
  • "We are not only amazed but proud of the response from our clients, employees, vendors, and local communities.
  • Their generosity is helping fill tummies of over 5,600 hungry children in our communities."
  • For the Pack The 'Pack campaign, BCTCares has partnered with local backpack program charities who will purchase and distribute food using the funds donated.

Coursera Reports Third Quarter 2023 Financial Results

Retrieved on: 
Thursday, October 26, 2023

Coursera, Inc. (NYSE: COUR) today announced financial results for its third quarter ended September 30, 2023.

Key Points: 
  • Coursera, Inc. (NYSE: COUR) today announced financial results for its third quarter ended September 30, 2023.
  • For more information regarding the non-GAAP financial measures discussed in this press release, please see "Non-GAAP Financial Measures" and "Reconciliation of GAAP to Non-GAAP Financial Measures" below.
  • We have provided a reconciliation of GAAP to non-GAAP financial measures in the financial statement tables for our historical non-GAAP financial results included in this press release.
  • As previously announced, Coursera will hold a conference call to discuss its third quarter 2023 performance today, October 26, 2023, at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time).

California Water Service Group Announces Election of Jeffrey Kightlinger to Board of Directors

Retrieved on: 
Thursday, October 26, 2023

SAN JOSE, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- California Water Service Group (Group) (NYSE: CWT) today announced the election of Jeffrey Kightlinger, 63, to the Group’s Board of Directors, effective Nov. 1, 2023.

Key Points: 
  • SAN JOSE, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- California Water Service Group (Group) (NYSE: CWT) today announced the election of Jeffrey Kightlinger, 63, to the Group’s Board of Directors, effective Nov. 1, 2023.
  • Kightlinger has the distinction of having been the longest serving Chief Executive Officer of the Metropolitan Water District of Southern California, the largest municipal water supplier in the nation.
  • In this capacity, he oversaw the agency’s $1.8 billion budget along with water and power operations serving 19 million residents in Southern California.
  • A renowned expert in water law, particularly Colorado River law, Kightlinger now owns Acequia Consulting, LLC, which provides strategic advice on water and energy issues.

RYVYL Appoints George Oliva as Chief Financial Officer

Retrieved on: 
Thursday, October 19, 2023

SAN DIEGO, CA, Oct. 19, 2023 (GLOBE NEWSWIRE) -- RYVYL Inc. (NASDAQ: RVYL) ("RYVYL" or the "Company"), a leading innovator of payment transaction solutions leveraging proprietary blockchain ledger and electronic token technology for the diverse international markets, today announced that it has appointed George Oliva as Chief Financial Officer of the Company, replacing former Interim Chief Financial Officer, Gene Jones.

Key Points: 
  • SAN DIEGO, CA, Oct. 19, 2023 (GLOBE NEWSWIRE) -- RYVYL Inc. (NASDAQ: RVYL) ("RYVYL" or the "Company"), a leading innovator of payment transaction solutions leveraging proprietary blockchain ledger and electronic token technology for the diverse international markets, today announced that it has appointed George Oliva as Chief Financial Officer of the Company, replacing former Interim Chief Financial Officer, Gene Jones.
  • George Oliva has over 30 years of experience as a senior finance professional, with a background in corporate finance, treasury, financial planning and analysis, international tax, and strategic planning.
  • Prior to joining RYVYL, he was Chief Financial Officer and Corporate Secretary for WiSA Technologies, Inc. since 2019.
  • As Interim Chief Financial Officer of SpineEx, Inc., a California-based medical equipment manufacturer, Mr. Oliva was responsible for managing the company’s financial, human resources and information technology departments.

Kalahari Resorts & Conventions, Home to America’s Largest Indoor Waterparks, Breaks Ground in Spotsylvania County, Virginia

Retrieved on: 
Friday, October 20, 2023

Kalahari Resorts and Conventions , home to America’s Largest Indoor Waterparks, broke ground in Spotsylvania County, Virginia — it’s fifth resort — on Friday, October 20, 2023.

Key Points: 
  • Kalahari Resorts and Conventions , home to America’s Largest Indoor Waterparks, broke ground in Spotsylvania County, Virginia — it’s fifth resort — on Friday, October 20, 2023.
  • View the full release here: https://www.businesswire.com/news/home/20231020293917/en/
    The Nelson Family, owners of Kalahari Resorts & Conventions, home to America's Largest Indoor Waterpark Resorts, breaks ground on their fifth resort.
  • The 1.3 million square foot resort is set to open in Spotsylvania County, Virginia in 2026.
  • "Our family could not be prouder to call Spotsylvania County, Virginia home to our fifth Kalahari resort," said Todd Nelson, owner and founder of Kalahari Resorts.

Vilya Appoints Cyrus Harmon, Ph.D., as Chief Executive Officer

Retrieved on: 
Tuesday, October 17, 2023

VILYA, Inc. (Vilya), a biotechnology company creating a new class of medicines that precisely target disease biology, today announced the appointment of Cyrus Harmon, Ph.D., as its Chief Executive Officer.

Key Points: 
  • VILYA, Inc. (Vilya), a biotechnology company creating a new class of medicines that precisely target disease biology, today announced the appointment of Cyrus Harmon, Ph.D., as its Chief Executive Officer.
  • “I am very excited to join the phenomenal team at Vilya developing new macrocycle drugs,” said Harmon.
  • Previously, Harmon co-founded and served as CEO of Olema Oncology, a company focused on women’s cancers, before transitioning to the role of Chief Research Officer.
  • Harmon joins Katerina Leftheris, Ph.D., Vilya’s Chief Scientific Officer on the company’s leadership team.

neuro42 Receives Direct Investment and Appoints Surgical Robotics Industry Pioneer Fred Moll as Strategic Advisor

Retrieved on: 
Thursday, October 5, 2023

neuro42 also appointed Dr. Moll as strategic advisor.

Key Points: 
  • neuro42 also appointed Dr. Moll as strategic advisor.
  • “We are proud that Dr. Moll, renowned Medtech entrepreneur, has recognized our differentiated MRI-robotic technology platform and vision to change the surgical standard of care in neurosurgery, with a direct investment made to neuro42,” said Abhita Batra, Founder and Chief Strategy Officer of neuro42.
  • “We are also thrilled to welcome Dr. Moll as a strategic advisor to neuro42.
  • Earlier in his career, Dr. Moll founded and co-founded three other surgical robotics companies, including Intuitive Surgical, Inc. (ISRG), a world leader in surgical robotics, in 1995.

WSP Promotes Patrick Watz to Midwest District Transportation Leader

Retrieved on: 
Monday, October 16, 2023

Watz will guide strategic development and help position the firm in pursuit of new transportation projects throughout the 13-state Midwest district.

Key Points: 
  • Watz will guide strategic development and help position the firm in pursuit of new transportation projects throughout the 13-state Midwest district.
  • MINNEAPOLIS, Oct. 16, 2023 /PRNewswire/ - WSP, a leading engineering, environment, and professional services consultancy in the U.S., has named Patrick Watz as Midwest district transportation business line leader.
  • In his prior role at WSP, Watz led the nine-state Plains District with responsibility for the strategic direction of all business lines.
  • WSP's Midwest district includes Illinois, Indiana, Iowa, Kansas, Kentucky, Minnesota, Michigan, Missouri, Nebraska, North Dakota, Ohio, South Dakota and Wisconsin.

Specific Biologics Announces Additional Investment and Appointment of Experienced Biotechnology Leader Steven Kanner, PhD, to the Board of Directors

Retrieved on: 
Tuesday, October 10, 2023

Specific Biologics is an early-stage biotechnology company developing its proprietary two-site Dualase® platform gene editors to build a pipeline of treatments for serious genetic diseases.

Key Points: 
  • Specific Biologics is an early-stage biotechnology company developing its proprietary two-site Dualase® platform gene editors to build a pipeline of treatments for serious genetic diseases.
  • TORONTO, Oct. 10, 2023 /PRNewswire/ - Specific Biologics Inc. ("Specific"), a venture-backed, early-stage genome editing company, is pleased to announce it has appointed Steven Kanner, PhD, as an Independent Director.
  • The appointment coincides with renewed investment from Lumira Ventures and adMare BioInnovations to advance the preclinical development of therapeutics based on Specific's proprietary Dualase® platform gene editors.
  • The additional investment from Lumira Ventures and adMare BioInnovations will be used to advance preclinical testing of Dualase gene editors in liver, ocular and CNS disorders.